Literature DB >> 20222116

Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis.

Margalit E Rosenkranz1, David C Wilson, Anthony D Marinov, Alisha Decewicz, Patrick Grof-Tisza, David Kirchner, Brendan Giles, Paul R Reynolds, Michael N Liebman, V S Kumar Kolli, Susan D Thompson, Raphael Hirsch.   

Abstract

OBJECTIVE: Juvenile idiopathic arthritis (JIA) is a heterogeneous group of inflammatory diseases, and no clinically useful prognostic markers to predict disease outcome in children with JIA are currently available. Synovial fluid likely reflects the proteins present in the inflamed synovium. The purpose of this study was to delineate the synovial fluid proteome and determine whether protein expression differs in the different subtypes of JIA.
METHODS: Synovial fluid samples obtained from children with oligoarticular JIA, polyarticular JIA, or systemic JIA were compared. Two-dimensional gel electrophoresis for protein separation and matrix-assisted laser desorption ionization-time-of-flight mass spectrometry and quadripole time-of-flight mass spectrometry for protein identification were used for this study. Synovial fluid cells were analyzed by polymerase chain reaction (PCR) for the presence of haptoglobin messenger RNA (mRNA).
RESULTS: The synovial fluid proteome of the samples was delineated. The majority of proteins showed overexpression in JIA synovial fluid as compared with noninflammatory control samples. There were 24 statistically significantly differentially expressed spots (>2-fold change; P < 0.05) between the subtypes of JIA. PCR analysis revealed haptoglobin mRNA, suggesting that haptoglobin is locally produced in an inflamed joint in JIA.
CONCLUSION: Despite the similar histologic appearance of inflamed joints in patients with different subtypes of JIA, there are differences in protein expression according to the subtype of JIA. Haptoglobin is differentially expressed between the subtypes of JIA and is locally produced in an inflamed joint in JIA. Haptoglobin and other differentially expressed proteins may be potential biomarkers in JIA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20222116      PMCID: PMC2918379          DOI: 10.1002/art.27447

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  50 in total

1.  Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios.

Authors:  S D Thompson; L K Luyrink; T B Graham; M Tsoras; M Ryan; M H Passo; D N Glass
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome.

Authors:  Dominik J Schaer; Boris Schleiffenbaum; Michael Kurrer; Alexander Imhof; Esther Bächli; Jörg Fehr; Holger J Moller; Soren K Moestrup; Andreas Schaffner
Journal:  Eur J Haematol       Date:  2005-01       Impact factor: 2.997

3.  Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake.

Authors:  Satish P Ramachandra Rao; Richard Wassell; M Alexander Shaw; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2007-01-02

Review 4.  Cytokines in juvenile rheumatoid arthritis.

Authors:  F De Benedetti; A Ravelli; A Martini
Journal:  Curr Opin Rheumatol       Date:  1997-09       Impact factor: 5.006

5.  Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis.

Authors:  Hua Liao; Jiang Wu; Eric Kuhn; Wendy Chin; Betty Chang; Michael D Jones; Steve O'Neil; Karl R Clauser; Johann Karl; Fritz Hasler; Ronenn Roubenoff; Werner Zolg; Brad C Guild
Journal:  Arthritis Rheum       Date:  2004-12

6.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

7.  Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin.

Authors:  Julia Guetta; Merav Strauss; Nina S Levy; Lana Fahoum; Andrew P Levy
Journal:  Atherosclerosis       Date:  2006-07-03       Impact factor: 5.162

8.  Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.

Authors:  Lewis M Brown; Steve M Helmke; Stephen W Hunsucker; Romana T Netea-Maier; Simon A Chiang; David E Heinz; Kenneth R Shroyer; Mark W Duncan; Bryan R Haugen
Journal:  Mol Carcinog       Date:  2006-08       Impact factor: 4.784

9.  Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes.

Authors:  N Hyka; J M Dayer; C Modoux; T Kohno; C K Edwards; P Roux-Lombard; D Burger
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

10.  Immune complexes in juvenile rheumatoid arthritis: a comparison of four methods.

Authors:  T L Moore; P W Sheridan; R B Traycoff; J Zuckner; R W Dorner
Journal:  J Rheumatol       Date:  1982 May-Jun       Impact factor: 4.666

View more
  7 in total

1.  Autoimmune response to transthyretin in juvenile idiopathic arthritis.

Authors:  Cristina C Clement; Halima Moncrieffe; Aditi Lele; Ginger Janow; Aniuska Becerra; Francesco Bauli; Fawzy A Saad; Giorgio Perino; Cristina Montagna; Neil Cobelli; John Hardin; Lawrence J Stern; Norman Ilowite; Steven A Porcelli; Laura Santambrogio
Journal:  JCI Insight       Date:  2016-02-25

2.  Identification of a specific haptoglobin C-terminal fragment in arthritic synovial fluid and its effect on interleukin-6 expression.

Authors:  Hyo Jung Park; Mi-Kyung Oh; Nam-Hoon Kim; Mi-La Cho; In-Sook Kim
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

3.  A Contra Capture Protein Array Platform for Studying Post-translationally Modified (PTM) Auto-antigenomes.

Authors:  Kailash Karthikeyan; Kristi Barker; Yanyang Tang; Peter Kahn; Peter Wiktor; Al Brunner; Vinicius Knabben; Bharath Takulapalli; Jane Buckner; Gerald Nepom; Joshua LaBaer; Ji Qiu
Journal:  Mol Cell Proteomics       Date:  2016-05-02       Impact factor: 5.911

4.  Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis.

Authors:  David S Gibson; Keri Newell; Alexandra N Evans; Sorcha Finnegan; Gwen Manning; Caitriona Scaife; Catherine McAllister; Stephen R Pennington; Mark W Duncan; Terry L Moore; Madeleine E Rooney
Journal:  J Proteomics       Date:  2012-07-06       Impact factor: 4.044

5.  Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease.

Authors:  Sorcha Finnegan; Joanne Robson; Caitriona Scaife; Catherine McAllister; Stephen R Pennington; David S Gibson; Madeleine E Rooney
Journal:  Arthritis Res Ther       Date:  2014-01-13       Impact factor: 5.156

6.  Secretion of pro-inflammatory cytokines and chemokines and loss of regulatory signals by fibroblast-like synoviocytes in juvenile idiopathic arthritis.

Authors:  AnneMarie C Brescia; Megan M Simonds; Kathleen E Sullivan; Carlos D Rose
Journal:  Proteomics Clin Appl       Date:  2017-01-17       Impact factor: 3.494

7.  α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis.

Authors:  Ludwig Zeller; Pascal N Tyrrell; Stella Wang; Nadine Fischer; Johannes-Peter Haas; Boris Hügle
Journal:  Pediatr Rheumatol Online J       Date:  2022-08-13       Impact factor: 3.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.